Generate a tailored SOP for Dr. Francine Foss. Improve your application with a focused, well-structured draft.
Francine Foss is a professor in the Medicine Section of Medical Oncology at Yale Cancer Center, with internationally recognized expertise in adult lymphomas and stem cell transplantation. Dr. Foss has developed and tested therapies that have been used to treat thousands of cancer patients, significantly impacting the field of stem cell research. She pioneered a nationally established clinical trials program at Yale Cancer Center and previously held a position at Tufts New England Medical Center, where she designed and directed multi-center national clinical trials leading to FDA approval of novel therapies for lymphomas. Dr. Foss is a world expert in T cell lymphomas, having pioneered novel therapies and led several national studies. She initiated the T Cell Lymphoma Forum and co-founded the United States Cutaneous Lymphoma Consortium, currently serving as its president. Her research interests focus on exploring biological factors influencing lymphomas and improving patient outcomes through innovative treatments. Dr. Foss is involved in collaborative efforts to identify molecular targets for treatment in T cell lymphomas and leads a multidisciplinary clinical team at Smilow Cancer Center.
Yale Cancer Center • New Haven, CT
Professor in Medicine Section of Medical Oncology.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.